Response to: 'Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities' by Bossuyt et al
- PMID: 29936440
- DOI: 10.1136/annrheumdis-2018-213841
Response to: 'Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities' by Bossuyt et al
Keywords: disease activity; systemic lupus erythematosus; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE.Ann Rheum Dis. 2018 Jun;77(6):911-913. doi: 10.1136/annrheumdis-2017-212599. Epub 2018 Feb 9. Ann Rheum Dis. 2018. PMID: 29440000
-
Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities.Ann Rheum Dis. 2019 Aug;78(8):e76. doi: 10.1136/annrheumdis-2018-213821. Epub 2018 Jun 23. Ann Rheum Dis. 2019. PMID: 29936439 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
